TachoSil® Versus Surgicel® Original for the Secondary Treatment of Local Bleeding in Adult and Pediatric Patients Undergoing Hepatic Resection Surgery

NCT01192022 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
253
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Takeda